Endovia Health Sciences (EDVA) FCF Margin Growth (3y) (2015 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) FCF Margin Growth (3y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.50 Bn | 133.65 Bn | 2.84 Bn | -1,272.00 |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn | -2,228.00 |
| 3 | Argenx Se | 65.05 Bn | 59.86 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.11 Bn | 51.98 Bn | 52.00 Mn | -5,426.00 |
| 5 | Revolution Medicines | 44.71 Bn | 44.71 Bn | - | - |
| 6 | BeOne Medicines | 40.40 Bn | 35.31 Bn | 1.53 Bn | 9,545.00 |
| 7 | Alnylam Pharmaceuticals | 35.36 Bn | 32.05 Bn | 992.69 Mn | 4,612.00 |
| 8 | Royalty Pharma | 28.16 Bn | 27.32 Bn | - | -3,088.00 |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 14,060.00 |
| 10 | Endovia Health Sciences | 801,166.21 | 558,464.21 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -2.20 Mn |
| Dec 31, 2025 | 33,973.00 |
| Sep 30, 2025 | -55,104.00 |
| Jun 30, 2025 | 240,868.00 |
| Mar 31, 2025 | -105,872.00 |
| Dec 31, 2024 | 14,562.00 |
| Sep 30, 2024 | -13,598.00 |
| Jun 30, 2024 | -11,432.00 |
| Mar 31, 2024 | 8,037.00 |
| Dec 31, 2023 | 151,582.00 |
| Sep 30, 2023 | 32,276.00 |
| Jun 30, 2023 | 16,904.00 |
| Mar 31, 2023 | 75,724.00 |
| Dec 31, 2022 | -288,195.00 |
| Sep 30, 2022 | 9,171.00 |
| Jun 30, 2022 | 153,151.00 |
| Mar 31, 2022 | 2.71 Mn |
| Dec 31, 2021 | -10,507.00 |
| Sep 30, 2021 | -13,054.00 |
| Jun 30, 2021 | -11,974.00 |